Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Bourdenx

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Autophagy|January 14, 2016
Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseasesMathieu Bourdenx, Jonathan Daniel, Emilie Genin, et al.
Neurobiology of Disease|October 24, 2013
Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesiaMathieu Bourdenx, Anna Nilsson, Henrik Wadensten, et al.
Human Gene Therapy Methods|August 2, 2018
Systemic Gene Delivery by Single-Dose Intracardiac Administration of scAAV2/9 and scAAV2/rh10 Variants in Newborn RatsLucie Chansel-Debordeaux, Mathieu Bourdenx, Nathalie Dutheil, et al.
Plos Biology|February 4, 2022
Correction: Proteome-wide analysis of chaperone-mediated autophagy targeting motifsPhilipp Kirchner, Mathieu Bourdenx, Julio Madrigal-Matute, et al.
Plos Biology|June 1, 2019
Proteome-wide analysis of chaperone-mediated autophagy targeting motifsPhilipp Kirchner, Mathieu Bourdenx, Julio Madrigal-Matute, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 2, 2016
Targeting α-synuclein: Therapeutic optionsBenjamin Dehay, Mickael Decressac, Mathieu Bourdenx, et al.
Scientific Reports|May 26, 2017
Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesiaMatthieu F Bastide, Christelle Glangetas, Evelyne Doudnikoff, et al.
Neurobiology of Disease|April 16, 2017
In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brainsFabio Cavaliere, Loic Cerf, Benjamin Dehay, et al.
Neurobiology of Disease|March 14, 2015
D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassemblyPedro Barroso-Chinea, Marie-Laure Thiolat, Simone Bido, et al.
JCI Insight|August 23, 2019
Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathiesMarie-Laure Arotcarena, Mathieu Bourdenx, Nathalie Dutheil, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Autophagy|January 14, 2016
Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseasesMathieu Bourdenx, Jonathan Daniel, Emilie Genin, et al.
Neurobiology of Disease|October 24, 2013
Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesiaMathieu Bourdenx, Anna Nilsson, Henrik Wadensten, et al.
Human Gene Therapy Methods|August 2, 2018
Systemic Gene Delivery by Single-Dose Intracardiac Administration of scAAV2/9 and scAAV2/rh10 Variants in Newborn RatsLucie Chansel-Debordeaux, Mathieu Bourdenx, Nathalie Dutheil, et al.
Plos Biology|February 4, 2022
Correction: Proteome-wide analysis of chaperone-mediated autophagy targeting motifsPhilipp Kirchner, Mathieu Bourdenx, Julio Madrigal-Matute, et al.
Plos Biology|June 1, 2019
Proteome-wide analysis of chaperone-mediated autophagy targeting motifsPhilipp Kirchner, Mathieu Bourdenx, Julio Madrigal-Matute, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 2, 2016
Targeting α-synuclein: Therapeutic optionsBenjamin Dehay, Mickael Decressac, Mathieu Bourdenx, et al.
Scientific Reports|May 26, 2017
Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesiaMatthieu F Bastide, Christelle Glangetas, Evelyne Doudnikoff, et al.
Neurobiology of Disease|April 16, 2017
In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brainsFabio Cavaliere, Loic Cerf, Benjamin Dehay, et al.
Neurobiology of Disease|March 14, 2015
D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassemblyPedro Barroso-Chinea, Marie-Laure Thiolat, Simone Bido, et al.
JCI Insight|August 23, 2019
Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathiesMarie-Laure Arotcarena, Mathieu Bourdenx, Nathalie Dutheil, et al.
Pageof 6